BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Liquent Announces Strategic Partnership with eSA, Inc.


10/19/2010 6:53:19 AM

HORSHAM, Pa., Oct. 18 /PRNewswire/ -- Liquent, Inc. today announced it has entered into a strategic partnership with eSA, Inc., a leading solutions provider for regulatory information management and regulatory services within Asia. Through an exclusive agreement, eSA will now have the commercial and technical support responsibilities for Liquent's strategic offerings, Liquent InSight and Liquent SmartDesk.

"Liquent's continued goal of being the global leaders in regulatory management and submission publishing solutions is strengthened by our relationship with eSA," stated Rick Riegel, Liquent's Chief Executive Officer. "Continuing our growth within the Japanese market and throughout Asia Pacific is a key initiative for Liquent. By partnering with eSA and capitalizing on their regulatory experience, Liquent further solidifies its expanding presence in this region of the world."

"We are very pleased with our newly formed strategic partnership with Liquent," said Kosuke Omoda, eSA's CEO. "The Liquent name and their comprehensive suite of software products and regulatory solutions are recognized globally as the leaders in regulatory management and submission publishing. eSA is extremely excited to be working with such a strong solutions provider in the life sciences industry."

Together, eSA and Liquent will be hosting a seminar to discuss their strategic partnership as well as their products and services offerings that are now available locally to the Japanese market.


Date: October 20, 2010

Time: 13:00 17:00

Location:

-- Marunouchi Conference Square

Marunouchi Bldg. 8F

2-4-1 Marunouchi, Chiyoda,

Tokyo, JAPAN, 100-6307


Discussion Topics

-- Industry Keynote

-- eSA Solutions

-- Liquent Global Strategies

-- Liquent Product Roadmap




If you would like to join eSA and Liquent for this event please contact Shosyun Han, Manager of IT R&D, eSA at +81.(0)3-6421-7366 or uketuke@esaplus.com.

About Liquent

Liquent regulatory solutions provide software and related regulatory and clinical services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.

Liquent is owned by Marlin Equity Partners.

About Marlin Equity Partners

Marlin Equity Partners is a Los Angeles, California-based private investment firm with over $1 billion of capital under management. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries that are in the process of undergoing varying degrees of operational, financial or market-driven change where its capital base, industry relationships and extensive network of operational resources significantly strengthens a company's outlook and enhances value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 35 acquisitions. For more information, please visit www.marlinequity.com.

About eSA, Inc.

eSA is a solution provider for e-regulatory submissions in Asia. In July, 2010, eSA acquired SDPS of Cellec, which had offered the most established solution of e-regulatory software and services in Japan since 2003. With our professionals, eSA satisfies our clients in cost reduction, work efficiency, and core competence.

CONTACT: Rick Riegel, Chief Executive Officer, 215-328-4302

SOURCE Liquent, Inc.



Read at BioSpace.com

Liquent
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES